 But the news this week is that treating obstructive sleep apnea with a type 2 diabetes medication may offer new hope for sufferers of this sleep disorder. Monjaro or Zepbound as the weight loss one drug has led to a significant decrease in the number of breathing interruptions during sleep, Doug.